Next-generation cancer diagnostics and therapy guidance of lung and breast cancer patients using mass spectrometry-based proteomics (Q84323)
Jump to navigation
Jump to search
Project Q84323 in Poland
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Next-generation cancer diagnostics and therapy guidance of lung and breast cancer patients using mass spectrometry-based proteomics |
Project Q84323 in Poland |
Statements
1,747,280.0 zloty
0 references
1,747,280.0 zloty
0 references
100.0 percent
0 references
1 September 2018
0 references
31 August 2021
0 references
INSTYTUT BIOCHEMII I BIOFIZYKI POLSKIEJ AKADEMII NAUK
0 references
The proposal will establish a team in the field of mass spectrometry (MS)-based clinical proteomics in cancer research which will develop technologies to advance pre-clinical research and create practical applications towards use in the clinical laboratory. The aims are the advancement of cancer research, and improvement of cancer diagnostics, prognosis and therapy monitoring. The applicant is an expert in the field, with knowledge gained at research units in Canada and Poland. He brings eight years of experience in a flourishing field of targeted proteomics, with knowledge in applying its technology to translational and medical research, with great future potential in clinical applicability. The know-how will be transferred to three students and combined with interdisciplinary collaborations with medical doctors in Canada and Poland creating a team which will advance the field so it can enter the clinical realm and create specific applications for breast and lung cancer diagnosis. (Polish)
0 references
The proposal will establish a team in the field of mass spectrometry (MS)-based clinical proteomics in cancer research which will develop technologies to advance pre-clinical research and create practical applications towards use in the clinical laboratory. The goals are the advancement of cancer research, and improvement of cancer diagnostics, prognosis and therapy monitoring. The applicant is an expert in the field, with knowledge gained at research units in Canada and Poland. He brings eight years of experience in a flourishing field of targeted proteomics, with knowledge in applying its technology to translational and medical research, with great future potential in clinical applicability. The know-how will be transferred to three students and combined with interdisciplinary collaborations with medical doctors in Canada and Poland creating a team which will advance the field so it can enter the clinical realm and create specific applications for breast and lung cancer diagnosis. (English)
14 October 2020
0 references
La proposition mettra en place une équipe dans le domaine de la protéomique clinique basée sur la spectrométrie de masse (MS) dans la recherche sur le cancer, qui mettra au point des technologies permettant de faire progresser la recherche préclinique et de créer des applications pratiques en vue d’une utilisation en laboratoire clinique. Les objectifs sont l’avancement de la recherche sur le cancer et l’amélioration du diagnostic du cancer, du pronostic et de la surveillance thérapeutique. Le candidat est un expert dans le domaine, avec des connaissances acquises dans des unités de recherche au Canada et en Pologne. Il apporte huit ans d’expérience dans le domaine de la farine de protéomique ciblée, avec des connaissances dans l’application de sa technologie à la recherche translationnelle et médicale, avec un grand potentiel pour l’avenir en matière d’applicabilité clinique. Le savoir-faire sera transféré à trois étudiants et combiné à des collaborations interdisciplinaires avec des médecins au Canada et en Pologne, créant une équipe qui fera progresser le domaine afin qu’elle puisse entrer dans le domaine clinique et créer des applications spécifiques pour le diagnostic du cancer du sein et du poumon. (French)
30 November 2021
0 references
Identifiers
POIR.04.04.00-00-4647/17
0 references